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Abstract 
AIM: To determine the relationship between Chlamydia Trachomatis infections with patency tubal and non-
patency tubal occurrence in infertile women. 
METHODS: This research was an observational analytic research with a cross-sectional study. This research was 
conducted at Haji Adam Malik General Hospital Medan, Pramita Laboratory Medan and Medical Faculty of 
Medicine Universitas Sumatera Utara. Laboratory on October 2017 until the number of samples was fulfilled. The 
samples were women who were referred to Pramita Laboratory Medan for hysterosalpingography procedure in 
accordance which corresponded to the inclusion criteria by using consecutive sampling technique. 
RESULTS: From this research, it was found that the most infertile women were aged 31-35 years, with the most 
infertility type was primary infertility (83,8%) with the longest infertility duration was ≥ 3 years (44%). From all 
samples who were infertile, 26% among them were positive to chlamydia infection. Eight from twelve people who 
were infected by Chlamydia Trachomatis experienced non-patency tubal (66.7%) with p-value = 0.001 which 
showed that there was a relationship between Chlamydia Trachomatis infection with patency tubal and non-
patency tubal occurrence in infertile women. 
CONCLUSION: The proportion of Chlamydia Trachomatis infection in tubal abnormality in this study was 66.7%, 
whereas Chlamydia Trachomatis infection in the normal tube was 13.2%. It was obtained that there was a 
significant relationship between Chlamydia Trachomatis infection with tubal abnormality (non-patency tubal) with 
p-value < 0.005 (p = 0.001). 
 
 
 
 
 
 
Introduction 
 
Infertility is the absence of pregnancy after 
marriage for 12 months or more, even though the 
couple has had sexual intercourse regularly without 
any contraceptive use [1]. About 10-15% of couples 
worldwide experience infertility problems. The number 
of infertile couples in the world as well as in Indonesia 
is increasing, where there is an increase in the 
number of infertile couples of around 2% every 5 
years [1]. In the United States, there are around 80 
million reproductive age couples recorded [2]. 
According to the World Health Organization 
(WHO), the prevalence of women with infertility in 
Indonesia in 2004 at the age of 20-24 years was 
21.3% and at the age of 25-29 years 16.8% [3].
 
Mashuri in 2006 against 93 infertile couples at dr. 
Pirngadi hospital Medan, found infertility originating 
from the wife's side as much as 49.46%, from the 
husband's side as much as 43.01% and 7.34% of both 
[4].
 
From the couple has had sexual intercourse 
regularly without using contraception, around 10-15% 
of couples worldwide experience infertility. Factors 
that cause infertility in women are divided into 
ovulation dysfunction factors (40%), pathological 
factors in the tube and peritoneal (40%), the presence 
of uterine problems (10%), and unexplained causes 
(10%). Genital infection by Chlamydia trachomatis is 
the main cause of tubal factor infertility [5], [6].
 
A case-control study conducted in Iran using 
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the Polymerase Chain Reaction (PCR) method 
showed that Chlamydia trachomatis was detected in 
32% in infertile women and 8.7% infertile women [5]. 
Likewise in Nigeria, the prevalence of IgG Chlamydia 
trachomatis was 74% in infertile women [6]. In a study 
conducted in Egypt by Ahmed et al., IgG positive 
Chlamydia trachomatis was found in 30 of 78 infertile 
patients with tubal occlusion [7]. The study by Sharma 
et al., in Africa showed that tubal damage caused by 
Chlamydia trachomatis infection contributed more of 
70 percent of infertility cases [8]. Various studies also 
found that the incidence of infertility due to tubal 
occlusion after infection with Chlamydia trachomatis 
ranged from 10-20% [9], [10], [11], [12]. From several 
studies it was also concluded that exposure to chronic 
infections from Chlamydia trachomatis is major 
predisposing factors resulting in chronic inflammation 
and causing damage to the tube resulting in infertility 
[13], [14]. 
Chlamydia trachomatis is an obligate 
intracellular microorganism that has the same cell wall 
as gram-negative bacteria and mainly infects the 
urethra, cervix, and tubal tract [15]. WHO reported the 
incidence of Chlamydia trachomatis infection is 
around 131 million worldwide with varying prevalence 
rates. in each country [16]. According to the 2014 
Centers for Disease Control and Prevention (CDC), 
Chlamydia trachomatis infection is a sexually 
transmitted disease with the highest incidence in the 
United States of 1.4 million [17]. Chlamydia 
trachomatis is also the most common cause of 
sexually transmitted infections often reported in 
Europe, with a prevalence of 1.7-17% in European 
women and 4.1% in women in Spain [18], [19]. 
Chlamydia trachomatis infection as much as 80% in 
women is asymptomatic so screening is needed so 
infection control can be achieved [20], [21].
 
Chlamydia trachomatis infection can generally 
be diagnosed using culture examination, antigen 
detection test, antibody test, and Nucleic Acid 
Amplification Technique test (TAAN), such as PCR 
and Ligase Chain Reaction (LCR) [21]. TAAN has 
sensitivity 80-90% with specificity > 98% and can be 
used to check large quantities of samples [22]. PCR is 
one of the TAAN techniques by amplifying millions of 
DNA segments in just a few hours. This method is 
very promising for the initial detection of Chlamydia 
trachomatis infection with a sensitivity of 95% and 
specificity of 99.3% [23]. 
To date, there is no accurate data regarding 
the overall prevalence of Chlamydia trachomatis 
infection in Indonesia. Research on the prevalence of 
Chlamydia trachomatis infection in patients who 
experience differences caused by tubal patency with 
tubal non-patency in Indonesia is also not yet 
available. This is because Chlamydia trachomatis 
examination is not routinely done in infertility 
management in various education centers even 
though this has been recommended in the national 
consensus on handling infertility. At Haji Adam Malik 
Hospital itself, which is a national referral hospital, it 
has not yet made the examination and prophylactic 
therapy of Chlamydia trachomatis as a routine 
examination and therapy in temporary infertility 
management. most are caused by Chlamydia 
trachomatis infection. 
So based on the above explanation, the 
author feels it is important to know the relationship 
between Chlamydia trachomatis infection and the 
incidence of tubal patency and non-patrol tubal 
infections in infertile women. 
 
 
Material and Methods 
 
 This study aims to determine the relationship 
between Chlamydia trachomatis infection and the 
incidence of tubal patency and non-tubal patency in 
infertile women, an observational analytic study with a 
cross-sectional study approach. This research was 
conducted at Haji Adam Malik General Hospital 
Medan, starting in October 2017 until the sample was 
fulfilled then the sample was taken to the FK USU 
Laboratory for examination. The study population was 
all infertile women who were referred from SpOG 
private practice in the Medan region to Pramitha 
Laboratory who agreed to take hysterosalpingography 
(HSG). 
 The method of selecting samples in this study 
was done by consecutive sampling, where all infertile 
patients who met the inclusion and exclusion criteria 
and agreed to be examined after informed consent 
was included in the study until the required number of 
subjects was fulfilled. 
 The sample size is calculated statistically 
based on the formula: 
Exp: 
 
n = Minimum number of samples needed 
Z = If α = 0.05 then Z score = 1.96 
p = Proportion of Chlamydia trachomatis infection in 
tubal occlusion 
q = 1- p = 0.15 
α = Degree of trust = 5% 
d = Precision = 10% 
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 Based on the above formula, the minimum 
number of samples obtained in this study were 50 
subjects. 
 Inclusion Criteria: 1. Women aged 21-40 
years; 2. Infertile women who are willing to do HSG 
examinations; 3. Infertile women who have never had 
abdominal and pelvic surgery, and have no myoma; 4. 
Willing to take part in the study and sign the consent 
form to take part in the study; and 5. Infertility occurs 
not due to male infertility. 
 Exclusion Criteria: Error results (illegible DNA 
on PCR). 
 
Work Arrangement 
 Subjects were explained about the purpose of 
the study, the examination procedure, and the 
benefits of the research obtained from this study. If 
the subject is willing to take part in this study, the 
subject of the statement letter agrees to participate in 
the study Patients who meet the inclusion and 
exclusion criteria are interviewed about identity which 
includes: name, age, gender, type, and duration of 
infertility. How it works to take endocervical smears: 1. 
The subject is given an explanation in advance about 
the examination to be carried out so that the patient 
does not feel afraid; 2. Using personal protective 
equipment, in the form of laboratory suits, gloves, 
masks, and glasses; 3. The patient was previously 
asked to urinate and remove underwear, then the 
patient was positioned lithotomy; 4. If there are too 
many secretions in the vulva, clean them first with a 
NaCl solution; 5. Then the left hand opens the labia 
may then input the bottom sims and sims up inside 
the vagina; 6. With the help of floodlights. Look for the 
cervical portion; 7. Observe whether there are 
mucopurulent endocervical secretions, erythema, 
erosion, and edema; 8. The cervix: cleanses the 
endocervix area with sterile gauze, then smears with a 
sterile swab; and 9. The sample was put into a 
microcentrifugation tube which was filled with TE 
buffer liquid and then taken to the integrated 
laboratory of the Faculty of Medicine, University of 
North Sumatra. 
 
Statistical Analysis 
 After all the data was collected, a descriptive 
analysis was conducted to determine the 
characteristics of the research subjects. Then 
bivariate analysis was performed to determine the 
relationship between Chlamydia trachomatis infection 
and the incidence of tubal patency and non-patency of 
the tube in women. To see the strength between the 
two variables, researchers used the Chi-square test in 
table 2 x 2 with a value of p < 0.05. 
Results  
 
Table 1 describes the characteristics of the 
study participants. In this study, it was found that the 
age most experienced Chlamydia Trachomatis 
infection was the age range in of 31-35 years, and the 
least was found in the age range of 21-25 years 
(Table 1). 
Table 1: Characteristics of Infertile Patients by Age, Type of 
Infertility and Duration of Infertility 
Characteristic 
Chlamydia trachomatis infection (PCR) 
Positive Negative Total 
n % n % n % 
Age       
21-25  1 7.7% 0 .0% 1 2.0% 
26 -30 2 15.4% 13 35.1% 15 30.0% 
31-35  3 23.1% 20 54.1% 23 46.0% 
36-40 7 43.9% 4 10.8% 11 22.0% 
Total 13 100.0% 37 100.0% 50 100.0% 
Infertility       
Primery 10 76.9% 31 83.8% 41 82.0% 
Secondary 3 23.1% 6 16.2% 9 18.0% 
Total 13 100.0% 37 100.0% 50 100.0% 
Duration       
1-2  1 7.7% 6 16.2% 7 14.0% 
2-3  7 53.8% 14 37.8% 21 42.0% 
≥ 3  5 38.5% 17 45.9% 22 44.0% 
Total 13 100.0% 37 100.0% 50 100.0% 
 
Table 1 also illustrates the characteristics of 
the type of infertility. From 50 research subjects, there 
were 41 subjects with primary infertility and 9 subjects 
who experienced secondary infertility. Of the 41 
subjects who experienced primary infertility, 10 people 
were infected with Chlamydia trachomatis 76.9% and 
31 subjects who were not infected with Chlamydia 
Trachomatis. Of the 9 subjects who experienced 
secondary infertility, 3 of them were infected with 
Chlamydia Trachomatis, and 6 were not infected with 
Chlamydia Trachomatis. 
Table 1 also illustrates the duration of 
infertility. From the table, it was found that the highest 
duration of infertility was > 3 years of parity, which 
was as many as 22 people (44%) and the least was 
with a duration of 1-2 years, as many as 7 people 
(14%). Of the 22 people who had > 3 years of 
infertility, 5 of them were infected with Chlamydia 
trachomatis, and 17 of them were not infected with 
Chlamydia trachomatis. Of the 7 people who had 1-2 
years of infertility, 1 of them was infected with 
Chlamydia trachomatis, and 6 of them were not 
infected with Chlamydia trachomatis. 
In Table 2 are shown the results obtained 
from 50 samples studied, and we can see that 13 
people (26%) were infected by Chlamydia 
trachomatis, and 37 people (74%) were not infected.  
 
Table 2: Frequency of Chlamydia trachomatis infection with 
PCR Method 
 PCR 
 Chlamydia trachomatis (+) Chlamydia trachomatis (-) Total 
Total  13 (26%) 37 (74%) 50 (100%) 
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In Table 3 we can see the prevalence of 
Chlamydia trachomatous infection in infertile women. 
As many as 8 people (66.7%) from 12 people with 
Non-Patent Tuba and as many as 5 people (13.2%) 
from 38 people with Tuba Patency have positive 
infection established with PCR. This is consistent with 
research by Sharma et al., in Africa showing that tubal 
damage caused by Chlamydia trachomatis infection 
accounts for more than 70% of cases of infertility. 
Table 3: Prevalence of Chlamydia trachomatis infection with 
Tuba Patent and Non-Patent Tuba Events in Infertile Women 
Chlamydia infection 
Tubal Patency 
Non-paten Patent 
n % n % 
Positive 8 66.7% 5 13.2% 
Negative 4 33.3% 33 86.8% 
Total 12 100% 38 100% 
 
 
Relationship Between Chlamydia 
 trachomatis infection and the incidence of 
 tubal patency and non-patent of the tuba in 
 infertile women  
Chlamydia trachomatis infection is one of the 
causes of infertility experienced by mothers due to 
tubal patency. 
Table 4 describes the proportion of Chlamydia 
trachomatis infection in tubal abnormalities. In this 
study, tubal abnormalities in the form of Non-Patent 
Tubes were found in 8 of 13 people infected with 
Chlamydia trachomatis (61.5%), higher than the 
proportion of Chlamydia trachomatis infection in 
normal tubal, i.e., 5 from 13 people (38.5%). 
Tablе 4: Relationship Between Chlamydia Trachomatis 
Infection with Patency Tubal and Non-Patency Tubal 
Tubal 
Patency 
Chlamydia Infection 
P 
Value 
Positive Negative Total 
N % N % N % 
Non patency 8 61.5% 4 10.8% 12 24.0% 
0.001 Patency 5 38.5% 33 89.2% 38 76.0% 
Total 13 100.0% 37 100.0% 50 100.0% 
 
 
 
Discussion 
 
Our results are not in accordance with several 
studies conducted by Ioannis which illustrate that the 
most Chlamydia trachomatis infections in the age 
range under 25 years in the USA. Due to this age, it is 
often associated with sexual experience, changing 
sexual partners and the number of new sexual 
partners. This may be different from the Indonesian 
state that does not adhere to free sex, so that hygiene 
and education factors are factors that influence the 
incidence of Chlamydia Trachomatis infection in the 
age range of 31-35 years, besides, it is said that the 
age at first sexual intercourse was also higher in the 
USA compared to developing countries [13]. The 
study conducted by Sayed on 150 infertile women in 
Iran, also illustrates that the most age for infection 
with Chlamydia Trachomatis is the age range of 25-
29, which is as many as 80 people [8]. 
This result is consistent with a study 
conducted by Haifa in Saudi Arabia, of 456 who 
experienced infertility, 368 were primary infertility, and 
89 were secondary infertility, according to a study 
conducted by Samiha, et al., conducted on 215 
infertile women, of which 172 among them are primary 
infertility (80%), and 43 other women are secondary 
infertility (20%). This occurs because patients with 
primary infertility have greater concern than 
secondary infertility patients who already have 
children so that awareness of self-examination and 
seeking medical assistance in dealing with infertility 
problems is better than patients with secondary 
infertility. Women suffer from primary infertility 
because of several risk factors, such as menarche 
above 16 years, irregularities of the menstrual cycle, 
age at marriage, and infection. 
This is in accordance with a study by 
Wafirotus in Indonesia in 42 infertile women who 
found that the duration of infertility was at most 
between 3 years and > 5 years, at 35.7%. Whereas in 
a study conducted by Gendarme et al., In Mongolia, of 
430 infertile couples, the longest infertile duration was 
4-8 years as many as 153 people (35.6%) and 2-4 
years as many as 152 people (35.4%). The thing that 
causes the duration of infertility is because the 
average couple will seek treatment for infertile 
problems over 2 years [30]. 
Our results are consistent with a study 
conducted by Sayed et al., of the 150 samples of 
infertile women studied, where 48 (32%) subjects 
were infected with Chlamydia trachomatis established 
through PCR [8]. 
Similar results were also found in the Sami et 
al. From 100 samples of infertile women in the study 
group, 36 subjects (36%) were infected by Chlamydia 
trachomatis. The cause of infertility in Chlamydia 
trachomatis sufferers was due to non-patent tuba. 
This is in line with the study by Sami et al., 
who examined the relationship between infertility and 
Chlamydia trachomatis infection in 200 women in Al-
Sadar hospital, illustrating that 60 people had tubal 
disorders and 25 (41.6%) people with Chlamydia 
trachomatis infection with a value of p < 0.005, 
illustrates the close relationship between Chlamydia 
trachomatis infection with tubal disorders that cause 
infertility in women. The disorder is due to obstruction 
or occlusion of the tube due to untreated Chlamydia 
trachomatis infection. Another study conducted by 
Swapnil Singh on 200 infertile women, found 10 
people suffering from Chlamydia trachomatis, and 
among those 10 people, all had tubal abnormalities, 
especially tubal occlusion. The most frequent 
occlusion site is in the fimbrial region as much as 
34%, followed by the Cornual section 32%, 
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hydrosalpinx 20.6%, ampullary section 8.6% and the 
isthmus section 3.4%. 
Another study conducted by Wafirotus et al., 
In 42 infertile women infected with Chlamydia 
Trachomatis, 76.1% had infertility due to tubal 
disorders, both those caused by perituba attachment, 
fimbriae phimosis, tubal occlusion, and hydrocephalic. 
The study conducted by Gendarme et al., in 
Mongolia, performed in 280 women who experienced 
infertility, 55.6% were caused by infection, and 36% 
were due to tubal abnormalities, namely bilateral tubal 
occlusion and pelvic adhesion [30]. Another study 
conducted in Saudi Arabia by Alffarajj et al in 100 
infertile women, found that 8% were infected by 
Chlamydia trachomatis, and 53.3% were due to tubal 
problems, this is because Chlamydia trachomatis that 
infects pelvic can spread to the uterus even to the 
fallopian tubes and cause local inflammation.  
Also the study conducted by Ahmed et al., 
showed that of 80 infertile women, 30 women (37.5%) 
were infected with Chlamydia trachomatis, and 23 of 
them had tubal occlusion (76.6%), p < 0.005. Where 
18 people experienced occlusion in the distal part, 
and 5 people experienced occlusion in the proximal 
part. 
All tubal disorders caused by Chlamydia 
trachomatis infection causing infertility, have a 
complex mechanism. The mechanism by which 
Chlamydia trachomatis induces inflammation and 
tissue damage has not been fully understood. 
However, it is known that Chlamydia trachomatis 
target cells are squamocolumnar epithelial cells of the 
endocervix and upper genital tract in women. Apart 
from this place, the initial response to infection 
appears to be primarily a polymorphonuclear 
leukocyte response. Infected epithelial cells in vitro 
produce interleukin-8 (IL-8) and other proinflammatory 
cytokines, which stimulate the initial neutrophil 
response. Lipopolysaccharide may be the dominant 
Chlamydia trachomatis antigen capable of inducing 
proinflammatory cytokines. 
Studies have explained the mechanism by 
which infected epithelial cells produce cytokines that 
direct the initial innate response and are obtained in 
Chlamydia trachomatis infection. Early neutrophil 
infiltration is followed by tissue infiltration with 
lymphocytes, macrophages, plasma cells, and 
eosinophils. In genital infections, plasma cells are 
generally present in large numbers. In genital 
diseases with biovar trachoma, lymphoid follicles 
(aggregate lymphocytes and macrophages in the 
submucosa) form when acute inflammation begins to 
subside. Thinning or loss of epithelium occurs around 
the follicle and can become necrotic when this 
disease occurs. When the infection begins to heal, 
fibrosis and scar tissue are formed. 
The results of this study indicate that there is 
a significant relationship with a value of p = 0.001 
where the value is smaller than 0.05, between 
Chlamydia trachomatis infection and the incidence of 
Non-Patent Tuba. 
In conclusion, a significant relationship was 
obtained between Chlamydia Trachomatis infection 
and tubal abnormalities (non-patent tubal) with a value 
of p = 0.001 (p < 0.05), with the most research 
subjects being the age group 31-35 years and the 
primary infertility type being 41 subjects (82%). the 
highest duration of infertility is ≥ 3 years (44%). The 
frequency of Chlamydia trachomatis infection with the 
PCR method found that 13 subjects (26%) of the 50 
subjects studied. The prevalence of Chlamydia 
trachomatis infection in tubal abnormalities in this 
study was 66.6%, while Chlamydia trachomatis 
infection in the normal tube was 13.2%. 
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